Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02803320 · ClinicalTrials.gov registry record · NA
To Assess the Safety of a Sunscreen Product
A NA study of Sunscreening Agents, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 1
- Study location
NCT02803320 is a NA study of Sunscreening Agents that has completed, run by Bayer. The registered enrollment target is 107 participants, above the 76-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (41% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02803320, a NA study of Sunscreening Agents, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study was to assess the safety and appropriateness of a sunscreen product for use on sport users, under supervised outdoor use conditions.
Conditions Studied
Interventions
- DRUG SPF 50 Y65 110 (BAY 987516)
Study Locations (1)
Florida
- - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2015-05-27 |
| Est. Completion | 2015-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02803320
The ClinicalTrials.gov registry entry for NCT02803320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 76-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (41% higher). The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sunscreening Agents appearing as the primary indexed condition, and to 1 intervention - of which SPF 50 Y65 110 (BAY 987516) is the first listed.
NCT02803320 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02803320 about?
NCT02803320 is a clinical study titled "To Assess the Safety of a Sunscreen Product". The objective of this study was to assess the safety and appropriateness of a sunscreen product for use on sport users, under supervised outdoor use conditions.
What is the current status of trial NCT02803320?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2015-05-27. Estimated completion is 2015-05-31.
What conditions does trial NCT02803320 study?
This clinical trial studies the following conditions: Sunscreening Agents.
What interventions are being tested in trial NCT02803320?
The interventions under investigation include: SPF 50 Y65 110 (BAY 987516) (DRUG).
Who is sponsoring clinical trial NCT02803320?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02803320 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sunscreening Agents
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Sunscreen Dispensers in Parks Visited by Teenagers
ACTIVE NOT RECRUITING · NA
-
Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products
COMPLETED · NA
-
Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating (821/2016)
COMPLETED · NA
-
Sun Protection Factor Assay (SPF Assay 204/2016)
COMPLETED · NA
-
18794 - Human Photo Toxicity Test
COMPLETED · NA
-
Sun Protection Factor Assay
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.